Ron Mayron - 18 Jan 2022 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
Issuer symbol
ENTX
Transactions as of
18 Jan 2022
Net transactions value
+$19,600
Form type
4
Filing time
19 Jan 2022, 15:07:03 UTC
Previous filing
11 Jan 2022
Next filing
04 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTX Ordinary Shares, par value NIS 0.0000769 per share Purchase $19,600 +7,000 $2.80 7,000 18 Jan 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.